# EDGAR Filing Document

**Accession Number:** 0001653477
**File Stem:** 0001653477-25-000119
**Filing Date:** 2025-10
**Character Count:** 14577
**Document Hash:** 0a017912ffad8016018b43b66def7315
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001653477-25-000119.hdr.sgml**: 20251023

**ACCESSION NUMBER**: 0001653477-25-000119

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20251023

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251023

**DATE AS OF CHANGE**: 20251023

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ingevity Corp
- **CENTRAL INDEX KEY:** 0001653477
- **STANDARD INDUSTRIAL CLASSIFICATION:** CHEMICALS & ALLIED PRODUCTS [2800]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 474027764
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37586
- **FILM NUMBER:** 251411322

**BUSINESS ADDRESS:**
- **STREET 1:** 4920 O'HEAR AVENUE
- **STREET 2:** SUITE 400
- **CITY:** NORTH CHARLESTON
- **STATE:** SC
- **ZIP:** 29405
- **BUSINESS PHONE:** 8437402300

**MAIL ADDRESS:**
- **STREET 1:** 4920 O'HEAR AVENUE
- **STREET 2:** SUITE 400
- **CITY:** NORTH CHARLESTON
- **STATE:** SC
- **ZIP:** 29405

?xml version='1.0' encoding='ASCII'? ngvt-20251023

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_______________________________________________________________________

**FORM 8-K** 

_______________________________________________________________________

**CURRENT REPORT**

**Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934**

**October 23, 2025** 

**Date of Report (date of earliest event reported)**

__________________________________________________________________________

![ingevitylogorgba11.jpg](ngvt-20251023_g1.jpg)

**INGEVITY CORPORATION**

**(Exact name of registrant as specified in its charter)**

__________________________________________________________________________

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **001-37586** | **47-4027764** |
| (State or other jurisdiction of incorporation or organization) | (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| **4920 O'Hear Avenue Suite 400** | **North Charleston** | **South Carolina** | **29405** |
| (Address of principal executive offices) | (Address of principal executive offices) | (Address of principal executive offices) | (Zip code) |

---

**Registrant's telephone number, including area code: 843-740-2300** 

**Not Applicable**

**(Former name or former address, if changed since last report)**

_____________________________________________________________________________________________________

---

| | |
|:---|:---|
| Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

---

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Stock ($0.01 par value)** | **NGVT** | **New York Stock Exchange** |

---

---

| | | |
|:---|:---|:---|
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
| ☐ | Emerging growth company | |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act | □ |

---

_____________________________________________________________________________________________________

------

**<u>ITEM 5.02.</u> <u>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</u>** 

On October 23, 2025, Ingevity Corporation ("Ingevity" or the "Company") announced that it has appointed Ruth Castillo as Senior Vice President and President, Performance Materials of the Company, effective as of November 10, 2025. Ms. Castillo will report directly to Ingevity's President and Chief Executive Officer.

*<u>Biographical Information</u>*

Ms. Castillo, age 48, is an accomplished business leader with over 25 years of experience in the chemicals, specialty materials and life science industries. Ms. Castillo most recently served as Vice President of Global Chemicals at Avantor, a global provider of products and services to the life sciences, advanced technology and applied materials industries, from January 2025 to October 2025. Prior to that role, Ms. Castillo served as Avantor's Vice President of Business Transformation from December 2022 to December 2024, Vice President of Supply Chain and Engineering from June 2020 to November 2022, and Vice President of Global Product Management from June 2018 to May 2020. Before joining Avantor in 2018, Ms. Castillo spent approximately 17 years with Celanese, a global chemical and specialty materials company, where she served in various leadership roles.

Ms. Castillo holds a Master of Business Administration from the University of Texas at Dallas and a Bachelor's Degree in Chemical Engineering from Universidad Iberoamericana in Mexico City.

Ms. Castillo has no family relationships with any director or executive officer of Ingevity. There are no arrangements or understandings between Ms. Castillo and any other person pursuant to which Ms. Castillo was selected as Senior Vice President and President, Performance Materials of Ingevity. Ms. Castillo is not a party to any transaction to which Ingevity is or was a participant and in which Ms. Castillo has a direct or indirect material interest subject to disclosure under Item 404(a) of Regulation S-K.

**<u>ITEM 7.01. REGULATION FD DISCLOSURE</u>**

A copy of the press release announcing the appointment of Ms. Castillo as Senior Vice President and President, Performance Materials of Ingevity is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

**<u>ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS</u>**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibit** |
| <u>[99.1](exhibit991102325.htm)</u> | Press release dated October 23, 2025. |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **INGEVITY CORPORATION** | **INGEVITY CORPORATION** |
| **(Registrant)** | **(Registrant)** |
| By: | /S/ RYAN C. FISHER |
|  | **Ryan C. Fisher** |
| **Senior Vice President, General Counsel and Corporate Secretary** | **Senior Vice President, General Counsel and Corporate Secretary** |

---

Date: October 23, 2025

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| ![image1.jpg](image1.jpg) | |
| ![image1.jpg](image1.jpg) | Ingevity Corporation<br>4920 O'Hear Avenue<br>Suite 400<br>North Charleston, SC 29405 USA<br>www.ingevity.com |
| **News** | **Contact:** <br>Caroline Monahan<br>843-740-2068<br>media@ingevity.com |
| | **Investors:** <br>John E. Nypaver, Jr.<br>843-740-2002<br>investors@ingevity.com |

---

**Ingevity names Ruth Castillo as senior vice president and president of Performance Materials**

*Veteran industry leader joins Ingevity to accelerate innovation and strategic growth across company's high performance activated carbon portfolio*

NORTH CHARLESTON, S.C., Oct. 23, 2025 – Ingevity Corporation (NYSE:NGVT) today announced that, effective November 10, 2025, Ruth Castillo has been appointed as president of Performance Materials, the company's unique activated carbon segment which has a long track record of consistent strong financial performance. She will also join Ingevity's executive leadership team as senior vice president.

Castillo most recently served as vice president of global chemicals at Avantor. She brings more than 25 years of global experience in the chemicals and materials industries, with proven ability to drive innovation, operational excellence and strategic growth. Over the course of her career, she has led high-value portfolios at companies including Avantor and Celanese, where she launched new products in highly technical, compliance-driven markets and led strategic initiatives that delivered significant profitability gains. Castillo will lead efforts to reinforce the activated carbon segment's market-leading position in evaporative emissions control and accelerate growth in emerging applications across the broader product portfolio.

"Ruth is a strategic and innovation-focused leader with a deep understanding of how to navigate complex businesses and unlock new growth opportunities," said Ingevity president and CEO, Dave Li. "Her experience driving business evolution in high-performing environments and her ability to align teams around market-driven priorities make her the right leader to guide Performance Materials into its next phase of innovation and strategic growth."

"I am honored to join Ingevity and lead a business with a strong foundation and reputation for excellence," said Castillo. "I look forward to working with our global teams to build on that success, accelerate innovation and unlock new opportunities for growth in our Performance Materials segment."

**About Ruth Castillo** 

Ruth Castillo is a senior executive with more than 25 years of global leadership experience in chemicals, specialty materials and life science industries. Known for leading complex, matrixed organizations, Castillo has consistently driven profitability, strategic growth and operational transformation across global markets. She has held high-impact roles across sales, procurement, marketing and general management, bringing a cross-functional perspective to executive decision-making. Her leadership is marked by a strong commercial orientation, deep market insight and a passion for advancing portfolio

growth through customer-focused innovation. She holds an MBA in International Management from the University of Texas at Dallas and a bachelor's in chemical engineering from Universidad Iberoamericana in Mexico City.

**Ingevity: Purify, Protect and Enhance**

Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and road technologies. Our products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components. Headquartered in North Charleston, South Carolina, Ingevity operates from 24 locations around the world and employs approximately 1,600 people. The company's common stock is traded on the New York Stock Exchange (NYSE:NGVT). For more information, visit ingevity.com.

**About Forward-Looking Statements** 

This press release contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," "believes," "anticipates" or similar expressions. Forward-looking statements may include, without limitation, the potential benefits of any leadership transition; expected financial positions, guidance, results of operations and cash flows; financing plans; business strategies and expectations. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, such factors detailed from time to time in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K as well as in our other filings with the SEC. These forward-looking statements speak only to management's beliefs as of the date of this press release. Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.

<br>